The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy
Open accessAbstract
Purpose Preoperative chemoradiotherapy (CRT) is part of the standard treatment of locally advanced rectal cancers. Tumour regression at the time of operation is desirable, but not much is known about the relationship between radiation dose and tumour regression. In the present study we estimated radiation dose-response curves for various grades of tumour regression after preoperative CRT. Methods and Materials A total of 222 patients, treated with consistent chemotherapy and radiotherapy techniques, were considered for the analysis. Radiotherapy consisted of a combination of external beam radiotherapy and brachytherapy. Response at the time of operation was evaluated from the histopathological specimen and graded on a five point scale (TRG1-5). The probability of achieving complete, major and partial response was analyzed using ordinal logistic regression, and the effect of including clinical parameters in the model was examined. The radiation dose response relationship for a specific grade of histopathological tumour regression was parameterized in terms of the dose required for 50% response, D50,i, and the normalized dose-response gradient, γ50,i. Results A highly significant dose–response relationship was found (p=0.002). For complete response (TRG1) the dose-response parameters were D50,TRG1=92.0 Gy (95% CI: 79.3 to 144.9 Gy), γ50,TRG1=0.982 (0.533 to 1.429), and for major response (TRG1-2) D50,TRG1&2=72.1 Gy (65.3 to 94.0 Gy), γ50,TRG1&2=0.770 (0.338 to 1.201). Tumour size and N-category both had a significant effect on the dose-response relationships. Conclusions This study has demonstrated a significant dose-response relationship for tumour regression after preoperative CRT for locally advanced rectal cancer for tumour dose levels in the range of 50.4 to 70 Gy, which is higher than the dose-range usually considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
Mandard, A.-M., Dalibard, F., Mandard, J.-C., Marnay, J., Henry-Amar, M., Petiot, J.-F., Roussel, A., Jacob, J.-H., Segol, P., Samama, G., et al. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2680::aid-cncr2820731105>3.0.co;2-c · Cited by 2,044
Maas, M., Nelemans, P. J., Valentini, V., Das, P., Rödel, C., Kuo, L.-J., Calvo, F. A., García-Aguilar, J., Glynne-Jones, R., Haustermans, K., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70172-8 · Cited by 1,945
Gérard, J.-P., Conroy, T., Bonnetain, F., Bouché, O., Chapet, O., Closon-Dejardin, M.-T., Untereiner, M., Leduc, B., Francois, É., Maurel, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7629 · Cited by 1,731
Aschele, C., Cionini, L., Lonardi, S., Pinto, C., Cordio, S., Rosati, G., Artale, S., Tagliagambe, A., Ambrosini, G., Rosetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.4911 · Cited by 763
Gérard, J.-P., Azria, D., Gourgou-Bourgade, S., Martel-Laffay, I., Hennequin, C., Etienne, P.-L., Vendrely, V., François, E., de La Roche, G., Bouché, O., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.8376 · Cited by 747
Bouzourene, H., Bosman, F. T., Seelentag, W., Matter, M., & Coucke, P. (2002) · Cancer · doi:10.1002/cncr.10327 · Cited by 285
Held, K. D. (2010) · International Journal of Radiation Biology · doi:10.3109/09553002.2010.496030 · Cited by 241
Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer
O'Neill, B. D., Brown, G., Heald, R., Cunningham, D., & Tait, D. M. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70202-4 · Cited by 214
Chemoradiotherapy for Rectal Cancer: An Updated Analysis of Factors Affecting Pathological Response
Sanghera, P., Wong, D. W. Y., McConkey, C. C., Geh, J. I., & Hartley, A. (2008) · Clinical Oncology · doi:10.1016/j.clon.2007.11.013 · Cited by 182
Cited by
Appelt, A. L., Pløen, J., Harling, H., Jensen, F. S., Jensen, L. H., Jørgensen, J. C. R., Lindebjerg, J., Rafaelsen, S. R., & Jakobsen, A. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00120-5 · Cited by 557
Self-citationThe multidisciplinary management of rectal cancer
Keller, D. S., Berho, M., Perez, R. O., Wexner, S. D., & Chand, M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0275-y · Cited by 359
Metadata
- Authors
- Appelt, A. L., Pløen, J., Vogelius, I. R., Bentzen, S. M., & Jakobsen, A.
- Venue
- International Journal of Radiation Oncology*Biology*Physics
- Publisher
- Elsevier BV
- Published
- 2013-01
- Volume
- 85
- Issue
- 1
- Pages
- 74-80
- ISSN
- 0360-3016 (ISSN-L)
- OpenAlex
- W1976964541
- Cited by
- 292
- References
- 20
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.